News & Updates

Nomogram spots malnutrition in cancer patients

10 Sep 2021

A nutritional features-based clustering analysis is a viable method to identify malnutrition early in cancer patients, suggests a study.

Nomogram spots malnutrition in cancer patients

10 Sep 2021

Prophylaxis with high-dose methotrexate suppresses isolated CNS relapse risk in DLBCL

10 Sep 2021

High-dose methotrexate (HDMTX) helps prevent isolated central nervous system (CNS) relapse in patients with diffuse large B cell lymphoma (DLBCL), a recent study has found. On the other hand, HDMTX seems to have no impact on systemic CNS relapse, systemic relapse, or survival.

Prophylaxis with high-dose methotrexate suppresses isolated CNS relapse risk in DLBCL

10 Sep 2021

PPIs safe to use with capecitabine-based NACRT for locally advanced rectal cancer

10 Sep 2021

Concomitant use of proton pump inhibitors (PPIs) with capecitabine-based neoadjuvant chemoradiotherapy (NACRT) for locally advanced rectal cancer (LARC) is safe and does not result in any adverse pathologic or oncological outcome, reports a study.

PPIs safe to use with capecitabine-based NACRT for locally advanced rectal cancer

10 Sep 2021

Double immunochemical faecal occult blood test most cost-effective CRC screening strategy

10 Sep 2021

While any colorectal cancer (CRC) screening strategy proves more cost-effective compared with no screening, double immunochemical faecal occult blood test appears to be the most economical, according to a study from China.

Double immunochemical faecal occult blood test most cost-effective CRC screening strategy

10 Sep 2021

Reduced-dose S1 + oxaliplatin combo therapy preserves QoL in older patients with mCRC

10 Sep 2021 by

The combination of reduced-dose S1 and oxaliplatin (SOx) chemotherapy preserves quality of life (QoL) and physical function in vulnerable older patients with metastatic colorectal cancer (mCRC), according to a subgroup analysis of the NORDIC9* study presented at ESMO GI 2021.

Reduced-dose S1 + oxaliplatin combo therapy preserves QoL in older patients with mCRC

10 Sep 2021

Antibiotic exposure tied to increased early-onset CRC risk

09 Sep 2021 by

Antibiotic exposure may be associated with an increased risk of early-onset colorectal cancer (CRC), according to a study from Scotland presented at ESMO GI 2021.

Antibiotic exposure tied to increased early-onset CRC risk

09 Sep 2021

COVID-19 vaccines elicit weaker antibody response in multiple myeloma patients

09 Sep 2021

Patients with myeloma mount a neutered humoral immune response following vaccination for the coronavirus disease 2019 (COVID-19), especially when receiving antibody therapy, a recent study has found.

COVID-19 vaccines elicit weaker antibody response in multiple myeloma patients

09 Sep 2021

Topotecan suppresses lethal SARS-CoV-2 inflammation

09 Sep 2021 by

Mount Sinai and University of Hong Kong (HKU) researchers find topotecan to be protective against hyperinflammation and death in preclinical models of coronavirus disease 2019 (COVID-19).

Topotecan suppresses lethal SARS-CoV-2 inflammation

09 Sep 2021

Obesity may influence survival in metastatic castration-resistant prostate cancer

08 Sep 2021 by

The obesity paradox, where obesity appears to confer a protective effect, was noted in metastatic castration-resistant prostate cancer (CRPC), with improved survival outcomes among obese patients with metastatic CRPC, according to a study from EAU21.

Obesity may influence survival in metastatic castration-resistant prostate cancer

08 Sep 2021

Rasburicase use for tumour lysis syndrome management needs improvement

08 Sep 2021

Use of rasburicase for the management of patients with tumour lysis syndrome in inpatient and outpatient settings may still be improved, suggests a study.

Rasburicase use for tumour lysis syndrome management needs improvement

08 Sep 2021

News & Updates

Filter by Specialty:

Specialty:

Nomogram spots malnutrition in cancer patients

Nomogram spots malnutrition in cancer patients

Prophylaxis with high-dose methotrexate suppresses isolated CNS relapse risk in DLBCL

Prophylaxis with high-dose methotrexate suppresses isolated CNS relapse risk in DLBCL

PPIs safe to use with capecitabine-based NACRT for locally advanced rectal cancer

PPIs safe to use with capecitabine-based NACRT for locally advanced rectal cancer

Double immunochemical faecal occult blood test most cost-effective CRC screening strategy

Double immunochemical faecal occult blood test most cost-effective CRC screening strategy

Reduced-dose S1 + oxaliplatin combo therapy preserves QoL in older patients with mCRC

Reduced-dose S1 + oxaliplatin combo therapy preserves QoL in older patients with mCRC

Antibiotic exposure tied to increased early-onset CRC risk

Antibiotic exposure tied to increased early-onset CRC risk

COVID-19 vaccines elicit weaker antibody response in multiple myeloma patients

COVID-19 vaccines elicit weaker antibody response in multiple myeloma patients

Topotecan suppresses lethal SARS-CoV-2 inflammation

Topotecan suppresses lethal SARS-CoV-2 inflammation

Obesity may influence survival in metastatic castration-resistant prostate cancer

Obesity may influence survival in metastatic castration-resistant prostate cancer

Rasburicase use for tumour lysis syndrome management needs improvement

Rasburicase use for tumour lysis syndrome management needs improvement